Prospective, Explorative, Research Study with Women to Investigate Menstruation Leakage At Night

March 14, 2025 updated by: Essity Hygiene and Health AB
The aim of this study is to investigate why and when menstruation leakages occur during sleep while using protective pads at night. Participants will be asked to use a specially designed pad during menstruation and to answer questions.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden
        • Essity Study site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Women with heavy menstruation

Description

Inclusion Criteria:

  1. Women ≥ 18 years
  2. Participant is mentally and physically able to participate in this study
  3. Written informed consent to participate in this study
  4. Participant with currently heavy menstruations regularly experiencing nocturnal leakages
  5. Participant is a regular user of nocturnal menstruation pads
  6. Participant is willing to use the prototype pad according to the protocol
  7. Willingness to take picture of used pads and transfer to study sponsor anonymously during study duration
  8. Available internet connection and device for taking pictures and data transfer (photo upload)
  9. Underwear size M or L

Exclusion Criteria:

  1. Known allergies or intolerances to one or several components of the study prototype
  2. Participants without regular menstruation, pregnant or perimenopausal subjects
  3. Participants not experiencing nocturnal leakages
  4. Participants with pacemakers and/or implant defibrillator or having persons in the household that have a pacemaker and/or implant defibrillator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Summary of leakage data of the menstruation pad in correlation with participats movements and position at leakage occasion.
Time Frame: 2025
Leakage data and body movement will be assessed
2025

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of questionnaire to understand the sleeping pattern during period
Time Frame: 2025
The answers received will be assessed.
2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2024

Primary Completion (Estimated)

May 30, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

October 9, 2024

First Submitted That Met QC Criteria

October 9, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 14, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • NOKTO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menstruation

Clinical Trials on Pads

Subscribe